A
ALDX
Aldeyra Therapeutics, Inc. Common Stock
$0.79
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Aldeyra Therapeutics, Inc. Common Stock in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$0.38
P/E
—
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: -$0.10
Nov 2
Posts
No posts about ALDX yet.
About Aldeyra Therapeutics, Inc. Common Stock
Aldeyra Therapeutics is a small US biotechnology company that develops drugs for eye diseases and other immune-related conditions. It has no approved product on the market, so it has no sales. It funds its research by raising money from investors, and it needs FDA approval for a drug before it can start earning revenue.